Activity of clotting factors in fresh-frozen plasma during storage at 4C over 6 days

Transfusion

Volumn 49, Issue 5, 2009, Pages 913-920

  Von Heymann, Christian ^a   Keller, Mareike Kristina ^b   Spies, Claudia ^b   Schuster, Michael ^b   Meinck, Kristian ^b   Sander, Michael ^b   Wernecke, Klaus Dieter ^b   Kiesewetter, Holger ^b   Pruss, Axel ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; ANTITHROMBIN III; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; FIBRINOGEN; FRESH FROZEN PLASMA; PROTEIN C; PROTEIN S; PROTHROMBIN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR ANTIGEN;

ADULT; ARTICLE; BACTERIUM CONTAMINATION; BLOOD CULTURE; BLOOD DONOR; BLOOD STORAGE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; QUALITY CONTROL; TEMPERATURE MEASUREMENT;

BACTERIA; BACTERIOLOGICAL TECHNIQUES; BLOOD COAGULATION FACTORS; CRYOPRESERVATION; HUMANS; PLASMA; QUALITY CONTROL; TIME FACTORS;

EID: 65349102280     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.02063.x     Document Type: Article

References (36)

1. O'Shaughnessy DF, Atterbury C, Bolton Maggs P, Murphy M, Thomas D, Yates S, Williamson LM, British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004 126 : 11 28.
2. Stanworth SJ. The evidence-based use of FFP and cryoprecipiate for abnormalities of coagulation tests and clinical coagulopathy. Hematol Am Soc Hematol Educ Progr 2007 2007 : 179 86.
3. Mueller MM, Bomke B, Seifried E. Fresh frozen plasma in patients with disseminated intravascular coagulation or in patients with liver diseases. Thromb Res 2002 107 : 9 17.
4. Bianco C. Choice of human plasma preparations for transfusion. Transfus Med Rev 1999 13 : 84 8.
5. Goldstein JN, Rosand J, Schwamm LH. Wafarin reversal in anticoagulant-associated intracerebral hemorrhage. Neurocrit Care 2008 9 : 277 83.
6. Ben-Tal O, Zwang E, Eichel R, Badalbev T, Hareuveni M. Vitamin K-dependent coagulation factors and fibrinogen levels in FFP remain stable upon repeated freezing and thawing. Transfusion 2003 43 : 873 7.
7. Gonzalez EA, Moore FA, Holcomb JB, Miller CC, Kozar RA, Todd SR, Cocanour CS, Balldin BC, McKinley BA. Fresh frozen plasma should be given earlier to patients requiring massive transfusion. J Trauma 2007 62 : 112 9.
8. Geeraedts LM Jr., Demiarl H, Schaap NP, Kamphuisen PW, Pompe JC, Froelke JP. "Blind" transfusion of blood products in exsanguinating trauma patients. Resuscitation 2007 73 : 382 8.
9. Illert WE, Butsch H, Nuber D, Howe J, Sänger W, Weidinger S. Long-term storage of fresh frozen plasma at -40°C. A multicenter study on the stability of labile coagulation factors over a period of 3 years. Infus Ther. Transfus Med 2001 28 : 189 94.
10. Paul-Ehrlich-Institut. Bekanntmachung der Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämotherapie) gemäss §§12 und 18 des Transfusionsgesetzes (TFG) - Änderungen und Ergänzungen 2007 (vom 17. April 2007). Bundesanzeiger 2007 92 : 5075.
11. O'Neill EM, Rowley J, Hansson-Wicher M, McCarter S, Ragno G, Valeri CR. Effect of 24-hour whole-blood storage on plasma clotting factors. Transfusion 1999 39 : 488 91.
12. Heger A, Roemisch J, Svae T-E. Stability of solvent-detergent-treated plasma and single-donor fresh-frozen plasma during 48h after thawing. Transfus Apher Sci 2005 33 : 257 67.
13. Cardigan R, Lawrie AS, Mackie IJ, Wiliamson LM. The quality of fresh-frozen plasma produced from whole blood stored at 4°C overnight. Transfusion 2005 45 : 1342 8.
14. Lamboo M, Poland DC, Eikenboom JC, Harvey MS, Groot E, Brand A, de Vries RR. Coagulation parameters of thawed fresh-frozen plasma during storage at different temperatures. Transfus Med 2007 17 : 182 6.
15. Bostroem F, Sjoedahl M, Wehlin L, Egberg N, Lundahl J. Coagulation parameters in apheresis and leukodepleted whole-blood plasma during storage. Transfusion 2007 47 : 460 3.
16. von Heymann C, Pruss A, Kastrup M, Marz S, Braun J, Kiesewetter H, Kox WJ, Spies C. Quality management regarding the use of blood products with special respect to the self-inspection program - a report from a university hospital. Transfus Med Hemother 2003 30 : 78 85.
17. Downes K, Wilson E, Yomtovian R, Sarode R. Serial measurement of clotting factors in thawed plasma stored for 5 days letter Transfusion 2001 41 : 570.
18. von Heymann C, Pruss A, Foer A, Volk T, Braun J, Roehrs A, Kiesewetter H, Spies C. Quality assurance of haemotherapy in anaesthesia. Auswertung eines 3-jährigen Erfahrungszeitraums. Anaesthesist 2005 54 : 107 16.
19. von Heymann C, Pruss A, Sander M, Finkeldey A, Ziemer S, Kalus U, Kiesewetter H, Salama A, Spies C. Thawing procedures and the time course of clotting factor activity in fresh frozen plasma: a controlled laboratory investigation. Anesth Analg 2006 103 : 969 74.
20. Akerblom O, Bremme K, Dackland AL, Fatah K, Suontaka AM, Blomback M. Freezing technique and quality of fresh frozen plasma. Infusionsther Transfusmed 1992 19 : 283 7.
21. Nifong TP, Light J, Wenk RE. Coagulant stability and sterility of thawed S-D-treated plasma. Transfusion 2002 42 : 1581 4.
22. Sidhu RS, Le T, Brimhall B, Thompson H. Study of coagulation factor activities in apheresed thawed fresh-frozen plasma at 1-6° C for five days. J Clin Apher 2006 21 : 224 6.
23. Saxena S, Odono V, Francis RB Jr., Endahl GL, Shulman IA. Can storage of thawed cryoprecipitate be extended to more than six hours? Am J Clin Pathol 1990 94 : 203 6.
24. Buchta C, Felfernig M, Höcker P, Macher M, Körmöczi GF, Quchenberger P, Heinzl H, Knöbl P. Stability of coagulation factors in thawed, solvent-detergent-treated plasma during storage at 4°C for 6 days. Vox Sang 2004 87 : 182 6.
25. Council of Europe. Guide to the preparation, use and quality assurance of blood components: recommendation No. R (95) 15. 13th ed. Strasbourg : Council of Europe Publishing 2007.
26. Levi M, de Jonge E, van der Poll T. Plasma and plasma components in the management of disseminated intravascular coagulation. Best Pract Res Clin Haematol 2006 19 : 127 42.
27. Smith JF, Ness PM, Moroff G, Luban NL. Retention of coagulation factors in plasma frozen after extended holding at 1-6°C. Vox Sang 2000 78 : 28 30.
28. Smak Gregoor PJ. Coagulation parameters of CPD fresh-frozen plasma and CPD cryoprecipitate-poor plasma after storage at 4°C for 28 days. Transfusion 1993 33 : 735 8.
29. Allen G, Hoffman M, Roberts HR, Monroe DM. Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of haemophilia. Br J Haematol 2006 134 : 314 19.
30. Osselaer JC, Debry C, Goffaux M, Pineau J, Calomme G, Dubuc E, Chatelain B, Vandendaele MC, Hsu J, Rheinschmidt M, Lin L. Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalen. Transfusion 2008 48 : 108 17.
31. Norda R, Knutson F, Berseus O, Åkerblom O, Nilsson-Ekdahl K, Stegmayr B, Nilsson B. Unexpected effects of donor gender on the storage of liquid plasma. Vox Sang 2007 93 : 223 8.
32. Beeck H, Hellstern P. In vitro characterization of solvent-detergent- treated plasma and quarantine fresh frozen plasma. Vox Sang 1998 74 : 219 23.
33. Scharrer I. Replacement therapy of coagulation factor preparations: antithrombin, FFP, PPSB, FXIII, rFVIIa. Haemostaseologie 2005 25 : 209 12.
34. Hess JR, Holcomb JB, Hoyt DB. Damage control resuscitation: the need for specific blood products to treat the coagulopathy of trauma. Transfusion 2006 46 : 685 6.
35. Ketchum L, Hess JR, Hiipala SH. Indications for early fresh frozen plasma, cryoprecipitate, and platelet transfusion in trauma. J Trauma 2007 60 : 51 8.
36. Scott EA, Puca KE, Pietz BC, DuChateau BK, Friedman KD. Comparison and stability of ADAMTS13 activity in therapeutic plasma products. Transfusion 2007 47 : 120 5.